SCHEMBL18166542

SCHEMBL18166542

Cc1ccc(CCNC(=O)Cn2cnc3c2c(=O)n(CCN(C)C)c(=O)n3C)cc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ TP53 P04637 3/20 0.50
▸ RXFP1 Q9HBX9 2/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ TRPA1 O75762 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ GAA P10253 2/20 0.47
▸ POLB P06746 2/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ TSHR P16473 1/20 0.44
▸ PDE4A P27815 1/20 0.44
▸ PDE4B Q07343 1/20 0.44
▸ PDE4C Q08493 1/20 0.44
▸ PDE4D Q08499 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18166533 0.94 CYP1A2 (0.56) CYP1A2CYP3A4TP53RXFP1MAPK1
SCHEMBL10178118 0.91 PDE4A (0.52) CYP1A2CYP3A4TP53TRPA1POLB
SCHEMBL10178000 0.91 GAA (0.55) CYP1A2CYP3A4TP53RXFP1MAPK1
SCHEMBL10178028 0.91 CYP1A2 (0.59) CYP1A2CYP3A4TP53RXFP1MAPK1
SCHEMBL1060801 0.87 CYP1A2 (0.72) CYP1A2CYP3A4TP53RXFP1MAPK1
SCHEMBL18166531 0.83 CYP1A2 (0.59) CYP1A2CYP3A4TP53RXFP1MAPK1
SCHEMBL10178119 0.83 PDE4A (0.61) CYP1A2CYP3A4TP53RXFP1MAPK1
SCHEMBL18166674 0.82 CYP1A2 (0.61) CYP1A2CYP3A4TP53RXFP1MAPK1
SCHEMBL1066585 0.81 CYP1A2 (0.69) CYP1A2CYP3A4TP53RXFP1MAPK1
SCHEMBL18166736 0.79 CYP1A2 (0.72) CYP1A2CYP3A4TP53RXFP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663295-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL ELI LILLY AND CO. (US) 2020-06-10 — — EP disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 — — EP disclosed
CN-101801362-B Methods and compositions for treating disorders HYDRA BIOSCIENCES INC 2014-01-22 — — CN disclosed
CN-101801362-A methods and compositions for treating disorders HYDRA BIOSCIENCES INC 2010-08-11 — — CN disclosed
Send feedback